For the quarter ending 2026-03-31, XXII had $2,396K increase in cash & cash equivalents over the period. -$3,143K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -3,261 | -2,808 | 5,489 | -7,735 |
| Impairment of long-lived assets - held for sale | - | 0 | 0 | 293 |
| (gain) loss on sale or disposal of property, plant, and equipment | - | 0 | 0 | 12 |
| Impairment of intangible assets | - | - | 111 | - |
| Impairment of long-lived assets | - | 150 | - | - |
| Amortization and depreciation | 206 | 218 | 235 | 459 |
| Amortization of right-of-use assets | 40 | 39 | 70 | 136 |
| Change in fair value of warrant liabilities | - | 0 | 33 | 174 |
| Other non-cash gains | - | 0 | 32 | - |
| Debt related charges included in interest expense | - | 0 | 602 | 984 |
| Provision for credit losses | 5 | -119 | -2 | 509 |
| Deferred income taxes | - | 7 | - | - |
| Equity-based compensation | 238 | 196 | 92 | 133 |
| Accrued expenses | - | - | -44 | 1,056 |
| Change in inventory reserves | 15 | -46 | 27 | -242 |
| Accounts receivable | 1,191 | 582 | -551 | 1,852 |
| Inventories | 35 | 1,374 | 430 | 246 |
| Prepaid expenses and other assets | -225 | -260 | -64 | 1,674 |
| Insurance recoveries | - | - | 9,500 | - |
| Accounts payable | 28 | -1,984 | -406 | -266 |
| Accrued payroll | - | - | -175 | -3 |
| Accrued expenses and other current liabilities | 307 | -253 | - | - |
| Accrued excise taxes and fees | 182 | -56 | -457 | 1,818 |
| Contract liabilities | 215 | 1,701 | - | - |
| Other liabilities | -77 | -1,155 | -246 | 14 |
| Net cash used in operating activities | -3,103 | 2,749 | -4,018 | -6,454 |
| Proceeds from the sale of property, plant and equipment | - | 0 | 0 | 770 |
| Issuance of 2025 gvb promissory note | - | 0 | 500 | - |
| Acquisition of patents, trademarks, and licenses | 7 | 739 | 16 | 59 |
| Payments received from 2025 gvb promissory note | - | 100 | - | - |
| Acquisition of property, plant and equipment | 40 | 16 | 6 | 39 |
| Net cash used in investing activities | -47 | -655 | -522 | 672 |
| Payments on notes payable | 120 | 293 | 271 | 638 |
| Proceeds from issuance of notes payable | - | 632 | 0 | 1,023 |
| Payments of penalties from long-term debt | - | 0 | 28 | - |
| Proceeds from issuance of common stock related to the atm | 200 | - | - | - |
| Payments of long-term debt | - | 0 | 3,291 | 1,017 |
| Payment of common stock issuance costs related to the atm | 136 | - | - | - |
| Net proceeds from warrant exercise | - | 0 | 0 | 5,075 |
| Principal payments on finance leases | 4 | - | - | - |
| Net proceeds from series a convertible preferred stock | - | 0 | 9,893 | - |
| Redemption of series a at par value | 9,650 | - | - | - |
| Payments of deferred offering costs | - | 130 | - | - |
| Net proceeds from series b convertible preferred stock | 15,256 | - | - | - |
| Net cash provided by (used in) financing activities | 5,546 | 209 | 6,303 | 4,443 |
| Net increase (decrease) in cash and cash equivalents | 2,396 | 2,303 | 1,763 | -1,339 |
| Cash and cash equivalents - beginning of period | 7,149 | 4,846 | 4,422 | - |
| Cash and cash equivalents - end of period | 9,545 | 7,149 | 4,846 | - |
22nd Century Group, Inc. (XXII)
22nd Century Group, Inc. (XXII)